The inhibitory action of exo- and endocannabinoids on [ 3H]GABA release are mediated by both CB 1 and CB 2 receptors in the mouse hippocampus

Rómeó D. Andó, Judit Bíró, Cecília Csölle, Catherine Ledent, B. Sperlágh

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Exogenous and endogenous cannabinoids play an important role in modulating the release of neurotransmitters in hippocampal excitatory and inhibitory networks, thus having profound effect on higher cognitive and emotional functions such as learning and memory. In this study we have studied the effect of cannabinoid agonists on the potassium depolarization-evoked [ 3H]GABA release from hippocampal synaptosomes in the wild-type (WT) and cannabinoid 1 receptor (CB 1R)-null mutant mice. All tested cannabinoid agonists (WIN55,212-2, CP55,940, HU-210, 2-arachidonoyl-glycerol, 2-AG; delta-9-tetra-hydrocannabinol, THC) inhibited [ 3H]GABA release in WT mice with the following rank order of agonist potency: HU-210 > CP55,490 > WIN55,212-2 >> 2-AG > THC. By contrast, 2-AG and THC displayed the greatest efficacy eliciting almost complete inhibition of evoked [ 3H]GABA efflux, whereas the maximal inhibition obtained by HU-210, CP55,490, and WIN55,212-2 were less, eliciting not more than 40% inhibition. The inhibitory effect of WIN55,212-2, THC and 2-AG on evoked [ 3H]GABA efflux was antagonized by the CB 1 receptor inverse agonist AM251 (0.5 μM) in the WT mice. In the CB 1R knockout mice the inhibitory effects of all three agonists were attenuated. In these mice, AM251 did not antagonize, but further reduced the [ 3H]GABA release in the presence of the synthetic agonist WIN55,212-2. By contrast, the concentration-dependent inhibitory effects of THC and 2-AG were partially antagonized by AM251 in the absence of CB 1 receptors. Finally, the inhibition of evoked [ 3H]GABA efflux by THC and 2-AG was also partially attenuated by AM630 (1 μM), the CB 2 receptor-selective antagonist, both in WT and CB 1 knockout mice. Our data prove the involvement of CB 1 receptors in the effect of exo- and endocannabinoids on GABA efflux from hippocampal nerve terminals. In addition, in the effect of the exocannabinoid THC and the endocannabinoid 2-AG, non-CB 1, probably CB 2-like receptors are also involved.

Original languageEnglish
Pages (from-to)145-152
Number of pages8
JournalNeurochemistry International
Volume60
Issue number2
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Endocannabinoids
Dronabinol
gamma-Aminobutyric Acid
Hippocampus
Cannabinoid Receptor Agonists
Cannabinoid Receptors
Knockout Mice
Cannabinoids
Synaptosomes
Cognition
Neurotransmitter Agents
Potassium
Learning
Inhibition (Psychology)

Keywords

  • Cannabinoid
  • CB receptor
  • CB receptor
  • GABA
  • Hippocampus
  • Release

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

The inhibitory action of exo- and endocannabinoids on [ 3H]GABA release are mediated by both CB 1 and CB 2 receptors in the mouse hippocampus. / Andó, Rómeó D.; Bíró, Judit; Csölle, Cecília; Ledent, Catherine; Sperlágh, B.

In: Neurochemistry International, Vol. 60, No. 2, 01.2012, p. 145-152.

Research output: Contribution to journalArticle

@article{fff49a649e26482f8905aa95a500e73b,
title = "The inhibitory action of exo- and endocannabinoids on [ 3H]GABA release are mediated by both CB 1 and CB 2 receptors in the mouse hippocampus",
abstract = "Exogenous and endogenous cannabinoids play an important role in modulating the release of neurotransmitters in hippocampal excitatory and inhibitory networks, thus having profound effect on higher cognitive and emotional functions such as learning and memory. In this study we have studied the effect of cannabinoid agonists on the potassium depolarization-evoked [ 3H]GABA release from hippocampal synaptosomes in the wild-type (WT) and cannabinoid 1 receptor (CB 1R)-null mutant mice. All tested cannabinoid agonists (WIN55,212-2, CP55,940, HU-210, 2-arachidonoyl-glycerol, 2-AG; delta-9-tetra-hydrocannabinol, THC) inhibited [ 3H]GABA release in WT mice with the following rank order of agonist potency: HU-210 > CP55,490 > WIN55,212-2 >> 2-AG > THC. By contrast, 2-AG and THC displayed the greatest efficacy eliciting almost complete inhibition of evoked [ 3H]GABA efflux, whereas the maximal inhibition obtained by HU-210, CP55,490, and WIN55,212-2 were less, eliciting not more than 40{\%} inhibition. The inhibitory effect of WIN55,212-2, THC and 2-AG on evoked [ 3H]GABA efflux was antagonized by the CB 1 receptor inverse agonist AM251 (0.5 μM) in the WT mice. In the CB 1R knockout mice the inhibitory effects of all three agonists were attenuated. In these mice, AM251 did not antagonize, but further reduced the [ 3H]GABA release in the presence of the synthetic agonist WIN55,212-2. By contrast, the concentration-dependent inhibitory effects of THC and 2-AG were partially antagonized by AM251 in the absence of CB 1 receptors. Finally, the inhibition of evoked [ 3H]GABA efflux by THC and 2-AG was also partially attenuated by AM630 (1 μM), the CB 2 receptor-selective antagonist, both in WT and CB 1 knockout mice. Our data prove the involvement of CB 1 receptors in the effect of exo- and endocannabinoids on GABA efflux from hippocampal nerve terminals. In addition, in the effect of the exocannabinoid THC and the endocannabinoid 2-AG, non-CB 1, probably CB 2-like receptors are also involved.",
keywords = "Cannabinoid, CB receptor, CB receptor, GABA, Hippocampus, Release",
author = "And{\'o}, {R{\'o}me{\'o} D.} and Judit B{\'i}r{\'o} and Cec{\'i}lia Cs{\"o}lle and Catherine Ledent and B. Sperl{\'a}gh",
year = "2012",
month = "1",
doi = "10.1016/j.neuint.2011.11.012",
language = "English",
volume = "60",
pages = "145--152",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - The inhibitory action of exo- and endocannabinoids on [ 3H]GABA release are mediated by both CB 1 and CB 2 receptors in the mouse hippocampus

AU - Andó, Rómeó D.

AU - Bíró, Judit

AU - Csölle, Cecília

AU - Ledent, Catherine

AU - Sperlágh, B.

PY - 2012/1

Y1 - 2012/1

N2 - Exogenous and endogenous cannabinoids play an important role in modulating the release of neurotransmitters in hippocampal excitatory and inhibitory networks, thus having profound effect on higher cognitive and emotional functions such as learning and memory. In this study we have studied the effect of cannabinoid agonists on the potassium depolarization-evoked [ 3H]GABA release from hippocampal synaptosomes in the wild-type (WT) and cannabinoid 1 receptor (CB 1R)-null mutant mice. All tested cannabinoid agonists (WIN55,212-2, CP55,940, HU-210, 2-arachidonoyl-glycerol, 2-AG; delta-9-tetra-hydrocannabinol, THC) inhibited [ 3H]GABA release in WT mice with the following rank order of agonist potency: HU-210 > CP55,490 > WIN55,212-2 >> 2-AG > THC. By contrast, 2-AG and THC displayed the greatest efficacy eliciting almost complete inhibition of evoked [ 3H]GABA efflux, whereas the maximal inhibition obtained by HU-210, CP55,490, and WIN55,212-2 were less, eliciting not more than 40% inhibition. The inhibitory effect of WIN55,212-2, THC and 2-AG on evoked [ 3H]GABA efflux was antagonized by the CB 1 receptor inverse agonist AM251 (0.5 μM) in the WT mice. In the CB 1R knockout mice the inhibitory effects of all three agonists were attenuated. In these mice, AM251 did not antagonize, but further reduced the [ 3H]GABA release in the presence of the synthetic agonist WIN55,212-2. By contrast, the concentration-dependent inhibitory effects of THC and 2-AG were partially antagonized by AM251 in the absence of CB 1 receptors. Finally, the inhibition of evoked [ 3H]GABA efflux by THC and 2-AG was also partially attenuated by AM630 (1 μM), the CB 2 receptor-selective antagonist, both in WT and CB 1 knockout mice. Our data prove the involvement of CB 1 receptors in the effect of exo- and endocannabinoids on GABA efflux from hippocampal nerve terminals. In addition, in the effect of the exocannabinoid THC and the endocannabinoid 2-AG, non-CB 1, probably CB 2-like receptors are also involved.

AB - Exogenous and endogenous cannabinoids play an important role in modulating the release of neurotransmitters in hippocampal excitatory and inhibitory networks, thus having profound effect on higher cognitive and emotional functions such as learning and memory. In this study we have studied the effect of cannabinoid agonists on the potassium depolarization-evoked [ 3H]GABA release from hippocampal synaptosomes in the wild-type (WT) and cannabinoid 1 receptor (CB 1R)-null mutant mice. All tested cannabinoid agonists (WIN55,212-2, CP55,940, HU-210, 2-arachidonoyl-glycerol, 2-AG; delta-9-tetra-hydrocannabinol, THC) inhibited [ 3H]GABA release in WT mice with the following rank order of agonist potency: HU-210 > CP55,490 > WIN55,212-2 >> 2-AG > THC. By contrast, 2-AG and THC displayed the greatest efficacy eliciting almost complete inhibition of evoked [ 3H]GABA efflux, whereas the maximal inhibition obtained by HU-210, CP55,490, and WIN55,212-2 were less, eliciting not more than 40% inhibition. The inhibitory effect of WIN55,212-2, THC and 2-AG on evoked [ 3H]GABA efflux was antagonized by the CB 1 receptor inverse agonist AM251 (0.5 μM) in the WT mice. In the CB 1R knockout mice the inhibitory effects of all three agonists were attenuated. In these mice, AM251 did not antagonize, but further reduced the [ 3H]GABA release in the presence of the synthetic agonist WIN55,212-2. By contrast, the concentration-dependent inhibitory effects of THC and 2-AG were partially antagonized by AM251 in the absence of CB 1 receptors. Finally, the inhibition of evoked [ 3H]GABA efflux by THC and 2-AG was also partially attenuated by AM630 (1 μM), the CB 2 receptor-selective antagonist, both in WT and CB 1 knockout mice. Our data prove the involvement of CB 1 receptors in the effect of exo- and endocannabinoids on GABA efflux from hippocampal nerve terminals. In addition, in the effect of the exocannabinoid THC and the endocannabinoid 2-AG, non-CB 1, probably CB 2-like receptors are also involved.

KW - Cannabinoid

KW - CB receptor

KW - CB receptor

KW - GABA

KW - Hippocampus

KW - Release

UR - http://www.scopus.com/inward/record.url?scp=84855215671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855215671&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2011.11.012

DO - 10.1016/j.neuint.2011.11.012

M3 - Article

C2 - 22133429

AN - SCOPUS:84855215671

VL - 60

SP - 145

EP - 152

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 2

ER -